NOV 24   

(1) Poll Results of the Extraordinary General Meeting Held on 24 November 2022; and (2) Grant of the Whitewash Waiver


NOV 03   

Monthly Return of Equity Issuer on Movements in Securities


OCT 30   

Despatch of Circular in relation to (I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme


OCT 30   

Notice of Extraordinary General Meeting


OCT 17   

Delay in Despatch of Circular in relation to (I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme


OCT 05   

Monthly Return of Equity Issuer on Movements in Securities


SEP 28   

Discloseable Transaction - Disposal of Listed Securities


SEP 26   

(I) Proposed Rights Issue on the Basis of One (1) Rights Share for Every One (1) Existing Share held on the Record Date; (II) Connected Transactions in relation to the Underwriting Agreement and Set Off of Shareholder’s Loans; (III) Application for Whitewash Waiver; and (IV) Possible Adjustments to the Share Options under the Share Option Scheme


SEP 02   

Monthly Return of Equity Issuer on Movements in Securities


AUG 30   

Unaudited Interim Results for the Six Months Ended 30 June 2022


AUG 30   

Terms of Reference of the Audit Committee


AUG 18   

Date of Board Meeting


AUG 17   

Discloseable Transaction - Disposal of Listed Securities


AUG 10   

Operational Update on Deep Longevity


AUG 05   

Monthly Return of Equity Issuer on Movements in Securities (Revised)


AUG 02   

Monthly Return of Equity Issuer on Movements in Securities


AUG 02   

Supplemental Announcement to the 2021 Annual Report


JUL 26   

Change of Address of Hong Kong Branch Share Registrar and Transfer Office


JUL 22   

Profit Warning


JUL 14   

Next Day Disclosure Return


JUL 06   

Deep Longevity published and granted the first microbiomic aging clock patent


JUL 05   

Operational Update on Deep Longevity


JUL 04   

Operational Update on Fortacin / Senstend


JUL 04   

Monthly Return of Equity Issuer on Movements in Securities


JUN 30   

Discloseable Transaction – Disposal of Listed Securities


Jun 01   

Monthly Return of Equity Issuer on Movements in Securities


May 26   

Poll Results of the Annual General Meeting Held on 26 May 2022


May 03   

Monthly Return of Equity Issuer on Movements in Securities


APR 29   

Supplemental Announcement to the Circular of the Company dated 27 April 2022


APR 26   

Notice of Annual General Meeting


APR 01   

Monthly Return of Equity Issuer on Movements in Securities


MAR 29   

Audited Final Results for the Year Ended 31 December 2021


MAR 17   

Date of Board Meeting


MAR 14   

Poll Results of the Extraordinary General Meeting Held on 14 March 2022


MAR 03   

Discloseable Transaction – Disposal of Listed Securities


MAR 01   

Monthly Return of Equity Issuer on Movements in Securities


FEB 24   

Notice of Extraordinary General Meeting


FEB 23   

Delay in Despatch of Circular


FEB 15   

Profit Warning


FEB 04   

Monthly Return of Equity Issuer on Movements in Securities


JAN 28   

Possible Major Transaction – Disposal Mandate in relation to the Possible Future Disposal of Listed Securities


JAN 04   

Monthly Return of Equity Issuer on Movements in Securities